GLAXOSMITHKLINE PLC 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
GLAXOSMITHKLINE PLC | 5,861,389 9.900% |
644,000 (+12.34%) |
Filing |
| 2021-02-12 5:12 pm Purchase |
2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
GLAXOSMITHKLINE PLC | 5,217,389 9.900% |
1,540,622 (+41.90%) |
Filing |